Democratizing Next-Generation Metabolomics

MetaSight has developed next generation Metabolomics/Lipidomics technologies for allowing unbiased, high throughput analyses of full metabolic profiles.

The Company's technology conducts profiling of blood samples at $1 per sample with less than one minute of
processing time.

MetaSight has the world’s largest metabolomics database coupled with a top quality longitudinal EHR dataset.

Investing partner / fund: